foundation for innovative therapies
Murray MF. [2003] Tryptophan depletion and HIV infection: a metabolic link to pathogenesis (PDF). The Lancet: Infectious Diseases Vol. 3: October 2003.

Murray MF. [2003] Nicotinamide: An oral antimicrobial agent with activity against both Mycobacterium tuberculosis and Human Immunodeficiency Virus. (PDF). Clinical Infectious Diseases 2003 Feb 15; 36(4).

Murray MF, Langan M, MacGregor RR. [2001] Increased plasma tryptophan in HIV-Infected patients treated with pharmacologic doses of nicotinamide. (PDF). Nutrition. 2001 Jul-Aug;17(7-8):654-6.

Murray MF. [1999] Nicotinamide as a potential AIDS preventive factor. Medical Hypoth. 53: 375-379.

Tang AM, Graham NMH, Saah AJ. [1996] Effects of micronutrient intake on survival in HIV infection. Am J Epidemiology. 143: 1244-1256.

Murray MF, Nghiem M, Srinivasan A. [1995] HIV decreases intracellular NAD. Biochem and Biophys Res Commun 212: 126-131.

Murray MF, Srinivasan A. [1995] Nicotinamide inhibits HIV in both chronic and acute in vitro infection. Biochem and Biophys Res Commun 210: 954-959.

Some of the articles above are in Adobe® Acrobat® format and require the Adobe Acrobat Reader® to be installed on your computer. If you would like to download this free software, click the button below.
Download Adobe Acrobat Reader